Heimdall Insights

Global Age-Related Macular Degeneration Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Age-Related Macular Degeneration Market was valued at $12.3 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $17.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Age-Related Macular Degeneration (AMD) market encompasses the pharmaceutical treatments, diagnostic tools, and management therapies for a progressive ocular disease that causes the loss of central vision. The scope includes both Wet AMD (neovascular) and Dry AMD (atrophic), specifically focusing on anti-VEGF therapies, complement inhibitors for geographic atrophy, and emerging gene therapies.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Age-Related Macular Degeneration Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Wet AMD (Neovascular)
  • Dry AMD (Atrophic)